Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detecting Expression Profiles Associated With Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia Patients Without Detectable Tyrosine Kinase Domain Mutations, Using Transcriptomics

NCT04219111 is registered in ClinicalTrials.gov with Sheffield Children's NHS Foundation Trust as lead sponsor.

NCT NCT04219111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04219111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detecting Expression Profiles Associated With Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia Patients Without Detectable Tyrosine Kinase Domain Mutations, Using Transcriptomics
Lead sponsor
Sheffield Children's NHS Foundation Trust
Phase
Observational
Overall status
Withdrawn
Start date
October 1, 2017
Completion date
May 4, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gene expression profiles in cml non-responders